Sep 10 |
Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass
|
Sep 6 |
Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
Sep 5 |
Aspira Women’s Health Selected as a Spoke for the Investor Catalyst Hub
|
Aug 27 |
Aspira Women’s Health Partners with Dorsata to Create New Clinical Workflow Tool for Adnexal Masses
|
Aug 14 |
Aspira Women's Health Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
Aug 5 |
Aspira Women’s Health’s Announces a Poster Presentation at the 27th Annual National Association of Nurse Practitioners in Women’s Health (NPWH) Women’s Healthcare Conference
|
Jul 29 |
Aspira Women’s Health Appoints Mr. John Ragard to its Board of Directors
|
Jul 17 |
Aspira Women's Health files to sell 2.5M shares of common stock for holders
|
Jul 9 |
Aspira Women’s Health Announces Closing of $1.9 Million Private Placement Equity Financing
|
Jun 13 |
Aspira Women’s Health Provides Commercial, Reimbursement and Cash Guidance Updates
|